Market revenue in 2023 | USD 12.1 million |
Market revenue in 2030 | USD 20.7 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.94% in 2023. Horizon Databook has segmented the UK biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
In the UK, many small-scale medical device companies and global manufacturers form the medical device manufacturing market. There are around 3,800 companies in the medical technology sector, and small and medium-sized enterprises hold 98% of the market.
There are many large companies in the U.S., which have subsidiaries in the UK. Orthopedics is the main strength of UK manufacturers, and fields like cardiovascular devices, imaging, and diagnostics play a major role in making the UK strong in the field of manufacturing medical devices.
The demand for regulatory affairs services such as legal representation is expected to rise, as many small and midsize manufacturers are exporting medical devices to the UK and are not having an established manufacturing facility in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the UK biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into UK biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account